Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
 

Search in our Online Store

Regenerative Medicine
Filter     Order     Display # 
Date Item Title
23 Jan 2007 Innocoll Receives FDA Approval to Commence a Phase 2 Clinical Trial for the Topical Treatment of Infected Diabetic Foot Ulcers With its CollaRx(R) GENTAMICIN
18 Jan 2007 Aastrom Treats Patients in Adult Stem Cell Clinical Trial for Osteonecrosis
17 Jan 2007 Marketing License Granted in The Netherlands for Adult Patients with Depression
13 Jan 2007 Biocoral, Inc. Announces the Results of the Final Report of its Prospective Randomised Clinical Multi-Centre Trial for Treatment of Hip Fractures Associated With Natural Bone Demineralization/or Low Bone Mass
06 Jan 2007 Tengion Launches First Phase II Clinical Trial of Regenerated Human Organ
23 Dec 2006 Results of Phase III Clinical Trials of the Idiopathic Pulmonary Fibrosis Treatment S-7701
16 Nov 2006 Pervasis Therapeutics Announces Successful Initial Safety Results of Phase I Trials of Vascugel(TM) Cell-Based Gel to Repair Arteries
11 Nov 2006 Advanced BioHealing Initiates CeladermTM Clinical Trial
04 Nov 2006 GenSci Expects Topical Molgramostim Gel Approval in 2007
17 Oct 2006 Pegasus Biologics Enters Wound Care Market With FDA Clearance for DermADAPT™ Biomatrix
13 Oct 2006 Innocoll, Inc. Receives FDA Approval for CollaGUARD™, A Collagen-Based
10 Oct 2006 Medtronic Receives FDA Approval To Study Infuse Bone Graft In The Cervical Spine
28 Sep 2006 Kensey Nash Announces 510(K) Clearance for Proprietary Bone Void Filler
16 Sep 2006 Aastrom Biosciences Reports Interim Data From Long Bone Non-Union Fracture Clinical Trial
13 Sep 2006 Ortec Announces Positive Results in Confirmatory Venous Leg Ulcer Trial
12 Sep 2006 Recent Publication Shows Open Tibial Fracture Patients Have Improved Outcomes with Medtronic’s Infuse Bone Graft (rhBMP-2)
07 Sep 2006 Addex commences Phase II clinical trials programme with ADX10059
30 Aug 2006 OrthoLogic Announces Results of Preliminary Interim Analysis of Phase 2b Clinical Trial of Chrysalin(R) (TP508) in Fracture Repair
27 Aug 2006 Olympus Expands Investment, Partnership with Cytori Therapeutics in Regenerative Medecine
25 Aug 2006 BioSyntech receives approval for Canadian BST-DermOn(R) pivotal clinical trial
16 Aug 2006 co.don AG - Excellent results of GCP-study EuroDISC on ADCT treatment of disc herniation and low back pain
12 Aug 2006 Genzyme Files for European Approval of Synvisc(R) In Ankle and Shoulder Indications
07 Aug 2006 Geron, University of Edinburgh Form Collaboration for Development of Three Cell Types Derived From Human Embryonic Stem Cells
07 Aug 2006 Advanced Viral Research (ADVR) Announces Results of Topical Animal Study Indicating AVR 118 Accelerates Wound Healing
01 Aug 2006 co.don® AG –successful arthroscopic treatment of ankle
01 Aug 2006 NIH Researchers Find RegeneRx's Drug Candidate Regulates Key Proteins Important in Wound Repair; Research Team Offers New Insights Into TB4's Mechanism of Action
26 Jul 2006 DOV Pharmaceutical, Inc. Announces Results of Carcinogenicity Studies for Bicifadine
25 Jul 2006 co.don AG - world wide revolutionary Enhancement of Product Portfolio and Indication
25 Jul 2006 Acologix Announces Results of AC-100 Initial Feasibility Study for Treatment of Periodontal Disease
25 Jul 2006 Acologix Announces Results of AC-100 Initial Feasibility Study for Treatment of Periodontal Disease
25 Jul 2006 TissueGene Initiates Phase I Clinical Trial with TG-C
20 Jul 2006 Company to File for CE Mark for European Distribution in Late 2006; Presently Evaluating Potential Partners for European Commercialization
19 Jul 2006 Cumulative Research Indicates Huperzine A Offers Potential Advantages Over AChE Inhibitors Used in U.S. to Treat Alzheimer's, Neuro-Hitech Study Finds
19 Jul 2006 Smith & Nephew Receives FDA Approval for EXOGEN 4000+* Bone Healing System
11 Jul 2006 BioMimetic Therapeutics Successfully Completes Enrollment in Three Orthopedic Pilot Clinical Trials for GEM OS1(TM) Bone Graft; Canadian Study Expanded to 60 Patients
06 Jul 2006 Ortec Issues Update on Its Three Technology Platforms for Regenerative Medicine and Stem Cells
05 Jul 2006 Geron Presents New Data That Document Progress in Development of Therapeutic Products from Human Embryonic Stem Cells
30 Jun 2006 Raymedica(R) Receives FDA Approval to Initiate Patient Enrollment in the HydraFlex(TM) Nucleus Arthroplasty System(TM) Clinical Trial
30 Jun 2006 Acologix’ AC-100 (Dentonin) Phase II Data On Dentin Formation In Humans Presented At The Annual Meeting Of The International Association For Dental Research
30 Jun 2006 Aastrom Biosciences Achieves U.S. Bone Fracture Clinical Milestone
29 Jun 2006 Cytomedix Announces Publication of the AutoloGel Diabetic Foot Ulcer Prospective Trial
27 Jun 2006 Stryker Submits Application to FDA For Spinal Indication For OP-1 Putty
27 Jun 2006 ViaCell Finalizes IDE and Announces Plans to Commence Clinical Trial of ViaCyte in Oocyte Cryopreservation
23 Jun 2006 Ortec Initiates Pre-Clinical Animal Model Study to Evaluate Fibrin Microbead Technology for Stem Cell Regeneration of Non-Union Bone Defects
22 Jun 2006 Hedgehog Pathway Activation Promotes Coronary Growth; Preclinical Data Published in Genes & Development
21 Jun 2006 Athenagen Advances Angiogenesis Drug to Clinical Testing
14 Jun 2006 CeraPedics Announces Results of P-15(TM) Non-Union/Delayed Union Pilot Study Published in International Orthopaedics
09 Jun 2006 Acologix Presents Preclinical Data On Bone Formation And Maturation Stimulated By AC-100 At The European Orthopedic Research Society Meeting
31 May 2006 Oral Compound BG-12 Achieves Primary Endpoint In Phase II Study Of Relapsing-Remitting Multiple Sclerosis
30 May 2006 Ortec Expects to File Humanitarian Device Exemption (HDE) Application With FDA Requesting Marketing Approval of Cryopreserved OrCel(R) for Use in Epidermolysis Bullosa Patients
 
<< Start < Prev 1 2 3 Next > End >>
Results 51 - 100 of 148

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics